This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in ...
All content for Empowered! is the property of Patient Empowerment Network and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in ...
Kidney Cancer Patient Expert Q&A: Dr. Moshe Ornstein
Empowered!
30 minutes
1 year ago
Kidney Cancer Patient Expert Q&A: Dr. Moshe Ornstein
START HERE bridges the expert and patient voice, enabling patients facing a kidney cancer diagnosis to feel comfortable asking precise questions of their healthcare team.In this program, Dr. Moshe Ornstein offers invaluable insights into renal cell carcinoma (RCC), equipping newly diagnosed patients with essential information on treatment priorities, as well as strategies for managing progression and recurrence.Download Resource Guide
Empowered!
This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in ...
